Status:
RECRUITING
Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Autism Spectrum Disorder
Autism or Autistic Traits
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to investigate the effects of multiple sessions of transcranial direct current stimulation (tDCS) delivered while participants complete tasks that target social l...
Detailed Description
Our long-term goal is to develop safe and effective treatments to reduce negative symptoms of social communication impairments to improve overall quality of life. Our central hypotheses are (1) active...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18-35 years
- Proficient in English
- Classification of autism or autism spectrum disorder on Autism Diagnostic Observation Scale, 2nd Edition (ADOS-2) or score of \>= 17 on Autism Quotient (AQ)
- Good or corrected vision and hearing
- Right-handed based on the Edinburgh Handedness Inventory
- Score of \>= 85 on Shipley-2
- Exclusion Criteria
- No known loss of consciousness for \> 5 minutes
- No immediate biological family members with a history of epilepsy or seizure disorder
- No major medical needs (e.g., neurological disorders such as a seizure disorder; long-term illness)
- No surgically implanted metal above the neck (example: metal pins or plates, cochlear implants, aneurysm clips, brain electrodes)
- No hospitalization for depression, anxiety, or substance abuse in the past 12 months
- No individuals who are currently pregnant
- No pacemakers
- No history of neurological disorders such as stroke, multiple sclerosis, bipolar disorder, encephalitis, epilepsy, seizure disorder, or amyotrophic lateral sclerosis
Exclusion
Key Trial Info
Start Date :
March 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06495684
Start Date
March 4 2025
End Date
May 31 2026
Last Update
October 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131